{"SPADE_UN_08071": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7001924 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7001924_B2", "Patent Type": "Granted Patent", "Publication Date": "2006-2-21", "Family Info": "EP1435932A2,EP1435932A4,US20030134904,WO2003024407A2,WO2003024407A3", "Patent Title": "Inhibitors of RNase P proteins as antibacterial compounds.", "Abstract": "The present invention features compounds useful for inhibiting RNase P activity. These compounds can be used as therapeutics for treating or preventing a variety of bacterial infections. The compounds belong to several classes including mono- and bis-guanylhydrazones, guanylhydrazone mimetics, and benzothiazolium compounds. Exemplary compounds are compounds of formula I: \nYâ€”(NRâ€²)kâ€”U1â€”(NRâ€³)Iâ€”Aâ€”(NR1)mâ€”U2â€”(NR2)nâ€”Zâ€ƒâ€ƒI with substituents as described herein."}], "Sequence Information": {"SPADE ID": "SPADE_UN_08071", "Sequence": "LRLLTPSHFTFVFRIGLTVAKKHVKRAHERNRIKRLTRESFRLHQHALDFVVLVKKGVADLDNRALTEALE", "Sequence Length": 71, "Peptide Name": "Sequence 67 from Patent US 7001924", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "LRV", "Absent Amino Acids": "CMOUWY", "Basic Residues": 20, "Acidic Residues": 7, "Hydrophobic Residues": 32, "Polar Residues": 43, "Positive Residues": 20, "Negative Residues": 7, "Mass": 8314.66, "PI": 11.24, "Net Charge": 13, "Hydrophobicity": -0.25, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18497", "Similarity": 0.9130434782608695, "Sequence": "LRLLTPSHFTRIGLTVAKKHVKRAHERNRIKRLTRELDFVVLTEAL"}, {"SPADE_ID": "SPADE_UN_08072", "Similarity": 0.9014084507042254, "Sequence": "LRLLTPSHFTFVFRIGLTVAKKNVKRAHERNRIKRLTRESFRLRQHELDFVVVAKRGVADLDNRALSEALE"}, {"SPADE_ID": "SPADE_UN_18498", "Similarity": 0.8913043478260869, "Sequence": "LRLLTPSHFTRIGLTVAKKNVKRAHERNRIKRLTRELDFVVLSEAL"}]}}}